How Soon Does Wegovy Kick In — and What Happens Before It Does?

Week one: you've taken the first injection and noticed almost nothing, that's normal

You've done the first injection. The dose is 0.25mg, which sits well below the therapeutic maintenance level, and many people spend this first week wondering whether something has gone wrong. It hasn't. The low starting dose exists specifically to let your digestive system adjust; the job of that first pen isn't weight loss, it's settling your body into the medicine. Some people report a mild reduction in appetite or a faint feeling of nausea after meals. Others feel nothing at all. Both are fine.

One misconception worth gently setting aside: Wegovy is not an appetite suppressant in the way a strong coffee briefly is. It works by activating GLP-1 receptors in the gut and brain, slowing gastric emptying and signalling fullness earlier. That process builds steadily as your dose increases, not in one surge on day one, and if you want to understand how long semaglutide takes to kick in, that page walks through what to expect at each stage. The semaglutide overview on this site covers the mechanism in more detail if you'd like the fuller picture.

Common early side effects cluster around the GI system: nausea, loose stools, mild indigestion. They're most likely to surface in the day or two after an injection and usually ease as the week goes on. Staying hydrated and keeping meals smaller and lower in fat during this adjustment period is the practical advice most prescribers give.

Weeks four to twelve: appetite starts shifting, the scales begin to move

By the four-week mark most people are titrating to 0.5mg, and this is where the appetite signal becomes harder to ignore. Portions feel like enough sooner. Food that used to be easy to overeat becomes less interesting. These are not dramatic changes (more a quiet recalibration) and many people describe them as the first moment the medicine feels real.

Weight on the scales typically starts moving between weeks six and ten for most patients, though the rate varies considerably depending on starting weight, diet, activity and individual biology. The STEP 1 trial, published in the New England Journal of Medicine, followed 1,961 adults over 68 weeks: average weight loss at the end was approximately 15% of body weight on semaglutide 2.4mg, compared to about 2.4% on placebo. That figure is a population average across everyone in the trial. Your trajectory will be your own.

The titration schedule continues through 1.0mg and then 1.7mg, each held for roughly four weeks before the next increase. Progress on the scales during this period can feel slower than expected, partly because the dose hasn't yet reached maintenance and partly because the body's initial response to reduced food intake often includes water loss before fat loss properly establishes. For a broader look at how the treatment works across the dose range, our Wegovy page sets out the full picture.

Week sixteen onwards: maintenance dose and where real results accumulate

Reaching 2.4mg, the standard maintenance dose, typically happens around week sixteen. This is where the evidence base is strongest and where the majority of weight loss in the clinical trials was recorded. It's also when consistency in lifestyle (protein intake, regular movement, adequate sleep) makes the biggest difference to outcomes.

Weight loss at maintenance is usually gradual rather than rapid: roughly 0.5 to 1kg per week on average in people following dietary guidance alongside the injection, though this slows over time as the body adjusts. A plateau between months four and six is common and is not a sign the medicine has stopped working. If you're curious about what to realistically expect from your first few months, the guide on how soon Wegovy starts to work explores the plateau question in more detail.

NICE guidance for semaglutide (Wegovy) states that if less than 5% weight loss has occurred after six months at the maintenance dose, continuing should be reviewed. That review is a clinical conversation, not an automatic stop, context, adherence and health markers all factor in. If you've been thinking about the broader question of what Wegovy costs alongside its timeline, the Wegovy treatment page sets out what a private prescription includes. Separately, the question of how quickly Wegovy takes effect compared to other medicines is one our prescribers hear regularly.

Beyond six months: what sustaining results actually looks like

The STEP 1 data shows that most weight loss occurs in the first 60 weeks, with a plateau emerging after that. Stopping the medicine abruptly typically leads to weight regain over the following months, which is why any decision to discontinue should involve a prescriber rather than a unilateral choice. Continued treatment, with regular clinical review, is how most people maintain their progress.

Alongside the medicine, the behaviours that support it matter consistently: prioritising protein at meals reduces muscle loss during weight loss, regular movement preserves metabolic rate, and building a sustainable rather than restrictive eating pattern prevents the boom-and-bust cycle that undermines long-term results. Our weight-loss treatment overview covers what evidence-based support alongside Wegovy looks like in practice.

One more practical note: the newer 7.2mg single-dose pen, approved by the MHRA in April 2026, is titrated up through the same schedule (starting at 0.25mg) so the timeline described here applies to anyone working towards that higher maintenance dose too. A prescriber confirms which dose pathway is appropriate at consultation. If you have questions about the process before then, the FAQs page covers the most common ones, and our team is reachable via the contact page.

Wegovy is a prescription-only medicine. A GPhC-registered Independent Prescriber at nume reviews every consultation personally before any treatment is issued. Check your eligibility and start a free consultation at the treatment page.